Akeso, Inc.
9926Biotechnology
HK$83.50−1.82%As of Oct 29vs prior close
- Market cap
- $9.8B
- P/E (TTM)
- –
- From 52W high
- −44.70%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥3.5B
- Net margin
- -28.03%
Nomior Score
47
Steady ProfileSpeculativeBottom 44% of the scored universe
Growth71
Quality56
Value41
Momentum41
Resilience37
Growth
+53.95%revenue a year over 3 fiscal years
YE22 CN¥837.7MLTM CN¥3.5B
Connections
Revenue to profitYE25
The net loss was 36% of revenue, wider by 12 pts on a year.